Combined inhibition of MNK signaling and BET proteins reveals TGM2 as a novel vulnerability in melanoma.
Méant A, Moussa O, Lebeau B, Gonçalves C, Richard VR, Cai F, Prabhu SA, Langke M, Guettler EM, Su J, Gagnon N, Zahedi RP, Borchers CH, Miller WH Jr, Del Rincón SV, Witcher M.
Méant A, et al. Among authors: miller wh jr.
J Invest Dermatol. 2024 Sep 30:S0022-202X(24)02160-2. doi: 10.1016/j.jid.2024.07.037. Online ahead of print.
J Invest Dermatol. 2024.
PMID: 39357785
Free article.
No abstract available.